Order results by:
| Issue | Title | |
| Vol 15, No 3 (2021) | Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins | Abstract similar documents |
| V. O. Bitsadze, E. V. Slukhanchuk, J. Kh. Khizroeva, M. V. Tretyakova, N. V. Pyatigorskaya, S. V. Akinshina, N. A. Makatsariya, K. E. Gotsiridze, N. N. Babaeva, K. N. Grigoreva, A. S. Shkoda, I. Elalamy, J.-C. Gris, S. Shulman | ||
| "... goal. The non-anticoagulant heparin properties allow to consider it as a candidate for pathogenetic ..." | ||
| Vol 16, No 2 (2022) | Anticoagulants: dose control methods and inhibitors | Abstract PDF (Eng) similar documents |
| V. O. Bitsadze, E. V. Slukhanchuk, J. Kh. Khizroeva, M. V. Tretyakova, V. I. Tsibizova, N. R. Gashimova, I. A. Nakaidze, I. Elalamy, J.-C. Gris, A. D. Makatsariya | ||
| "... These days, anticoagulants are in great demand. They are used as a prophylaxis for thromboembolic ..." | ||
| Vol 10, No 1 (2016) | ANTITHROMBOTIC THERAPY IN CANCER PATIENTS | Abstract similar documents |
| A. V. Vorobev, A. M. Chabrov, A. A. Savchenko, A. D. Makatsariya | ||
| "... into consideration pathogenetic aspects of hypercoagulation status in cancer patients: oral anticoagulants, heparin ..." | ||
| Vol 15, No 4 (2021) | Advisory Board conclusion following the discussion "Controversial issues of low molecular weight heparins use in obstetrics" | Abstract similar documents |
| article Editorial | ||
| "... heparins (LMWHs) have largely replaced unfractionated heparin as the anticoagulant. However, in case ..." | ||
| Vol 18, No 3 (2024) | Innovative approaches to assessing risk factors, diagnostics and treatment of neonatal thrombosis | Abstract similar documents |
| A. D. Makatsariya, A. V. Vorobev, A. V. Lazarchuk, S. E. Einullaeva, N. A. Gomenko, F. A. Magomedova, V. O. Bitsadze, J. Kh. Khizroeva, N. A. Makatsariya, V. B. Zubenko, M. V. Tretyakova, D. V. Blinov, F. E. Yagubova, N. R. Gashimova, K. N. Grigoreva, M. A. Ponimanskaya, O. N. Li, A. V. Mostovoi, A. L. Karpova, J-C. Gris, I. Elalamy | ||
| "... threshold values for natural blood coagulation inhibitors (protein C, protein S, antithrombin, heparin ..." | ||
| Vol 18, No 5 (2024) | Corrigendum to «Innovative approaches to assessing risk factors, diagnostics and treatment of neonatal thrombosis» (https://doi.org/10.17749/2313-7347/ob.gyn.rep.2024.530) | Abstract similar documents |
| A. D. Makatsariya, A. V. Vorobev, A. V. Lazarchuk, S. E. Einullaeva, N. A. Gomenko, F. A. Magomedova, V. O. Bitsadze, J. Kh. Khizroeva, N. A. Makatsariya, V. B. Zubenko, M. V. Tretyakova, D. V. Blinov, F. E. Yagubova, N. R. Gashimova, K. N. Grigoreva, M. A. Ponimanskaya, O. N. Li, A. V. Mostovoi, A. L. Karpova, J.-C. Gris, I. Elalamy | ||
| Vol 15, No 4 (2021) | Management of antithrombin III deficiency in pregnancy: a representative case and a literature review | Abstract PDF (Eng) similar documents |
| S. V. Akinshina, P. K. Genina, V. O. Bitsadze, J. Kh. Khizroeva, V. I. Tsibizova, A. D. Makatsariya | ||
| "... thrombotic and obstetric complications even despite using therapeutic doses of anticoagulants. Indications ..." | ||
| Vol 19, No 1 (2025) | Immune paradoxes of vaccine-induced thrombotic thrombocytopenia (VITТ), heparin-induced thrombocytopenia (HIT) and thrombosis: from general mechanisms to the unique VITТ and HIT course | Abstract similar documents |
| A. D. Makatsariya, S. V. Akinshina, A. V. Vorobev, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, N. A. Makatsariya, I. S. Kalashnikova, N. R. Gashimova, K. N. Grigoreva, I. A. Stepanov, I. M. Dikareva, A. Yu. Tatarintseva, A. V. Lazarchuk, A. R. Khisamieva, D. V. Blinov, P. Van Dreden, J.-Ch. Gris, I. Elalamy, G. Gerotziafas | ||
| "... management involves discontinuation of heparin and the initiation of using alternative anticoagulants ..." | ||
| Vol 14, No 2 (2020) | Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome | Abstract PDF (Eng) similar documents |
| A. D. Makatsariya, K. N. Grigoreva, M. A. Mingalimov, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, I. Elalamy, A. S. Shkoda, V. B. Nemirovskiy, D. V. Blinov, D. V. Mitryuk | ||
| "... “aggressive” intensive care should be applied. Low molecular weight heparin (LMWH) should be administered ..." | ||
| Vol 10, No 1 (2016) | DIRECT ORAL ANTICOAGULANTS | Abstract similar documents |
| I. Tzoran, B. Brenner | ||
| "... Several direct oral anticoagulants (DOACs), namely, apixaban, rivaroxaban, and dabigatran ..." | ||
| Vol 14, No 1 (2020) | Pathogenetically differentiated management of pregnancy in patients with retrochorial hematoma | Abstract similar documents |
| Kh. G. Sultangadzhieva, J. Kh. Khizroeva | ||
| "... anticoagulant, antiphospholipid antibodies (AFA), antibodies to cardiolipin, fi2-glycoprotein I, to annexin V ..." | ||
| Vol 8, No 1 (2014) | HELLP SYNDROME BENIGN OUTCOME CASE REPORT | Abstract similar documents |
| T. V. Karpenko, T. L. Smirnova | ||
| "... . Early diagnostics and timely surgery, pathogenetically based gestosis heparin therapy insured favourable ..." | ||
| Vol 8, No 1 (2014) | HELLP SYNDROME BENIGN OUTCOME CASE REPORT | Abstract similar documents |
| T. V. Karpenko, T. L. Smirnova | ||
| "... . Early diagnostics and timely surgery, pathogenetically based gestosis heparin therapy insured favourable ..." | ||
| Vol 16, No 2 (2022) | Prevention of recurrent fetal growth retardation in patients with circulating antiphospholipid antibodies and genetic thrombophilia | Abstract similar documents |
| E. A. Orudzhova, V. O. Bitsadze, M. V. Tretyakova, D. A. Doronicheva, F. Yakubova | ||
| "... Aim: to evaluate the effectiveness of using low molecular weight heparin (LMWH) and low-dose ..." | ||
| Vol 8, No 2 (2014) | THROMBOPHILIA, THROMBOSIS AND ANTITHROMBOTIC THERAPY IN CANCER PATIENTS | Abstract similar documents |
| A. V. Vorobev, A. D. Makatsaria | ||
| "... низкомолекулярными гепаринами. ..." | ||
| Vol 10, No 4 (2016) | PLACENTAL INSUFFICIENCY IN COMPLICATED PREGNANCY AND POSSIBILITY OF TREATMENT WITH DIPYRIDAMOLE | Abstract similar documents |
| A. D. Makatsariya, V. O. Bitsadze, D. Kh. Khizroeva, I. V. Khamani | ||
| "... insufficiency includes antiplatelet agents, low molecular weight heparins and vitamin and mineral ..." | ||
| Vol 8, No 3 (2014) | VENOUS THROMBOEMBOLISM IN RELATION TO OVARIAN HYPERSTIMULATION SYNDROME: AN APPROACH TO DETERMINING THE LOW-MOLECULAR-WEIGHT-HEPARIN DOSES AND ACTIVITY | Abstract similar documents |
| I. E. Zazerskaya, N. A. Osipova, T. V. Vavilova, L. V. Barabanova, K. S. Konradi | ||
| "... литературы относительно выбора дозы и длительности применения низкомолекулярных гепаринов для профилактики ..." | ||
| Vol 15, No 5 (2021) | Pathogenetically justified tactics of management of pregnancy with retrochorial hematoma | Abstract similar documents |
| K. G. Sultangadzhieva, N. N. Babaeva, E. S. Egorova, J. Kh. Khizroeva, M. G. Sultangadzhiev | ||
| "... in the genes of factor (F) V Leiden and prothrombin (FII) G20210A; blood levels of lupus anticoagulant (LA ..." | ||
| Vol 9, No 2 (2015) | Pregnancy in women with history of ischemic stroke and thrombophilia | Abstract similar documents |
| A. D. Makatsariya, S. V. Akinshina, V. O. Bitsadze, E. V. Zhuravleva, L. E. Idrisova, G. R. Abramyan | ||
| Vol 8, No 1 (2014) | PREGNANCY IN WOMEN WITH HISTORY OF ISCHEMIC STROKE AND THROMBOPHILIA | Abstract similar documents |
| S. V. Akinshina, A. D. Makatsariya, V. O. Bitsadze | ||
| Vol 15, No 3 (2021) | COVID-19 in pregnant women after assisted reproductive technologies receiving low molecular weight heparins | Abstract similar documents |
| N. S. Stuleva, A. L. Mishchenko | ||
| "... reproductive technologies (ART) receiving low molecular weight heparins (LMWH). All women suffered COVID-19 ..." | ||
| Vol 15, No 1 (2021) | Use of plasmapheresis in treatment of patients with unfavorable anamnestic pregnancy outcomes coupled to antiphospholipid antibodies | Abstract similar documents |
| D. R. Eremeeva, M. S. Zainulina, Yu. S. Dolgova, R. A. Shakhaliev, O. A. Silvanovich, L. A. Pavlova | ||
| "... Aim: to evaluate efficacy of plasmapheresis combined with low molecular weight heparins (LMWH ..." | ||
| Vol 14, No 4 (2020) | Errors of antithrombotic therapy in management of pregnancy and childbirth after in vitro fertilization and transfer of two embryos | Abstract similar documents |
| N. S. Stuleva, D. A. Doronicheva, I. V. Khamani, E. A. Orudzhova | ||
| "... due to increased number of women undergoing this technique. Low molecular weight heparins ..." | ||
| Vol 12, No 1 (2018) | THROMBOPHILIA AND ABNORMAL LOCATION OF PLACENTA | Abstract similar documents |
| V. B. Zubenko | ||
| Vol 10, No 4 (2016) | PRINCIPLES OF PREGRAVID PREPARATION AND MANAGEMENT OF PREGNANT WOMEN WITH PREECLAMPSIA IN THE BACKGROUND OF THROMBOPHILIA | Abstract similar documents |
| H. L. Atabaeva | ||
| "... weight heparin, vitamins and antioxidants in patients with preeclampsia and multigenic thrombophilia ..." | ||
| Vol 8, No 4 (2014) | CLINICAL PICTURE, DIAGNOSIS AND PREVENTION OF VENOUS THROMBOEMBOLIC COMPLICATIONS DURING PREGNANCY | Abstract similar documents |
| S. V. Akinshina, A. D. Makatsariya, V. O. Bitsadz, M. D. Andreeva | ||
| "... be the essential pathogenetic mechanism of thromboembolism associated with pregnancy. Low molecular weight heparin ..." | ||
| Vol 8, No 2 (2014) | THROMBOPHILIA AND THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH USE OF ASSISTIVE REPRODUCTIVE TECHNOLOGIES | Abstract similar documents |
| S. V. Akinshina, A. D. Makatsariya, V. O. Bitsadze, N. S. Stuleva, T. Ya. Mashkova | ||
| Vol 17, No 6 (2023) | Recurrent failure of ART, thrombosis and thrombophilia | Abstract similar documents |
| J. Kh. Khizroeva, A. S. Antonova, E. S. Egorova, N. A. Makatsariya | ||
| Vol 17, No 4 (2023) | What has changed over the year in the prevention of venous thromboembolic events in pregnant women and puerperas? | Abstract similar documents |
| V. O. Bitsadze, M. S. Zainulina, J. Kh. Khizroeva, M. G. Nikolaeva, A. D. Makatsariya | ||
| "... of low molecular weight heparins (LMWH) in pregnant women will allow to update current clinical ..." | ||
| Vol 12, No 1 (2018) | MANAGEMENT OF PREGNANCY AND DELIVERY IN A WOMAN WITH HOMOZYGOUS MUTATION OF PROTHROMBIN (Thr165Met) AND RECURRENT PULMONARY EMBOLISM ON THE BACKGROUND OF HORMONAL CONTRACEPTION | Abstract similar documents |
| N. M. Khamani | ||
| "... heparin under continuous monitoring of hemostasis and heparin dose correction. ..." | ||
| Vol 17, No 6 (2023) | Opportunities of using nadroparin calcium for prevention thrombotic complications at risk of coagulopathic bleeding | Abstract similar documents |
| T. A. Sushko, M. S. Zainulina | ||
| "... heparins (LMWHs) in pregnancy particularly nadroparin calcium for patients at high risk of VTEC and immune ..." | ||
| Vol 16, No 1 (2022) | Thrombosis risk and in vitro fertilization | Abstract similar documents |
| E. Grandone | ||
| "... -weight heparins (LMWH) are justified to be used as a preventive means. However, commonly recommended ..." | ||
| Vol 15, No 5 (2021) | Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses | Abstract PDF (Eng) similar documents |
| S. V. Akinshina, V. O. Bitsadze, J. Kh. Khizroeva, K. N. Grigorieva, E. V. Slukhanchuk, M. V. Tretyakova, V. I. Tsibizova, I. Elalamy, J.-C. Gris, B. Brenner, E. Grandone, C. Ay, A. D. Makatsariya | ||
| "... to the processes occurring in heparin-induced thrombocytopenia (HIT). All international and national organizations ..." | ||
| Vol 15, No 2 (2021) | Current approaches to the use of antiplatelet and anticoagulant drugs in pregnant women with thrombocytopenia caused by hemostasis activation | Abstract similar documents |
| O. L. Mysik, M. S. Zainulina | ||
| "... acetylsalicylic acid (ASA) and low molecular weight heparins (LMWH) in pregnant women with thrombocytopenia ..." | ||
| Vol 8, No 3 (2014) | BASIC PRINCIPLES OF TREATMENT OF ANEMIA AND THROMBOPHILIC STATUS VIN PREGNANT AND POSTPARTUM WOMEN | Abstract similar documents |
| E. S. Egorova | ||
| Vol 12, No 2 (2018) | Heparin prophylaxis of gestational complications in women with Factor V Leiden mutation (GA genotype) | Abstract similar documents |
| M. G. Nikolaeva, A. P. Momot, M. S. Zainulina, K. A. Momot, N. N. Yasafova | ||
| "... The aim of the study was to determine the efficacy of heparin prophylaxis in preventing pregnancy ..." | ||
| Vol 19, No 1 (2025) | Women's health in focus: contemporary challenges, therapeutic solutions and historical perspectives | Abstract similar documents |
| A. D. Makatsariya, A. V. Vorobev | ||
| "... -mediated thrombotic complications, including vaccine-induced thrombotic and heparin-induced ..." | ||
| Vol 13, No 3 (2019) | Significance of detecting antiphospholipid antibodies and genetic mutations of hemostasis for in vitro fertilization | Abstract similar documents |
| V. I. Linnikov | ||
| "... of pregnancy throughout the gestation period, anticoagulant therapy by low molecular weight heparins ..." | ||
| Vol 18, No 6 (2024) | Chemotherapy and hemostasis disorders | Abstract similar documents |
| E. V. Slukhanchuk, V. O. Bitsadze, A. G. Solopova, J. Kh. Khizroeva, K. N. Grigoreva, N. R. Gashimova, N. A. Makatsariya, D. V. Blinov, V. N. Galkin, A. Yu. Shatilina, E. M. Lyadnova, N. A. Shulga, L. T. Toguzaeva, S. Morkos, J.-C. Gris, I. Elalamy, G. Gerotziafas, A. D. Makatsariya | ||
| "... of external and internal coagulation pathways, decreased anticoagulant levels, platelet activation ..." | ||
| Vol 15, No 5 (2021) | Prophylaxis and management of venous thromboembolism during pregnancy and postpartum period | Abstract similar documents |
| V. Ya. Khryshchanovich, N. Ya. Skobeleva | ||
| "... -adjusted therapeutic-dose low molecular weight heparins (LMWH) represent the anticoagulant treatment ..." | ||
| Vol 15, No 6 (2021) | COVID-19 and thrombotic microangiopathy | Abstract PDF (Eng) similar documents |
| E. V. Sluhanchuk, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, A. S. Shkoda, O. P. Artyukov, V. I. Tsibizova, A. L. Mishchenko, K. N. Grigorieva, J.-С. Gris, E. Elalamy, A. D. Makatsariya | ||
| "... reduce mortality due to the novel disease. Heparins and direct oral anticoagulants are the mainstay ..." | ||
| Vol 11, No 3 (2017) | USEOFSODIUMBEMIPARININOBSTETRICPRACTICE. A CLINICAL CASE | Abstract similar documents |
| D. Kh. Khizroeva, D. V. Mitryuk | ||
| "... with antithrombotic therapy – low molecular weight heparin (sodium bemiparin). ..." | ||
| Vol 18, No 4 (2024) | Assessing the effectiveness of preventing placenta-associated complications in patients with burdened obstetric history and circulating antiphospholipid antibodies | Abstract similar documents |
| D. R. Eremeeva, M. S. Zainulina | ||
| "... . All pregnant women received therapy with low-dose aspirin (LDA) and low molecular weight heparin ..." | ||
| Vol 10, No 3 (2016) | ANTITHROMBOTIC THERAPY IN PATIENTS WITH METABOLIC SYNDROME AFTER ABDOMINAL DELIVERY | Abstract similar documents |
| A. V. Khromylev, A. D. Makatsariya | ||
| "... weight heparins (LMWH) after cesarean section at women with metabolic syndrome (MS). Materials ..." | ||
| Vol 19, No 3 (2025) | Haemostasis and metastasis: anticoagulants therapeutic potential in ovarian cancer | Abstract similar documents |
| A. V. Vorobev, V. O. Bitsadze, J. Kh. Khizroeva, A. G. Solopova, D. M. Mamchich, E. D. Mun, D. V. Blinov, J.-C. Gris, I. Elalamy, G. Gerotziafas, P. Van Dreden, A. D. Makatsariya | ||
| "... in patients with/without long-term anticoagulant therapy (АСТ) as a part of secondary prevention of thrombotic ..." | ||
| Vol 15, No 4 (2021) | Neonatal thrombosis: risk factors and principles of prophylaxis | Abstract PDF (Eng) similar documents |
| A. V. Vorobev, V. O. Bitsadze, J. Kh. Khizroeva, S. A. Potapkina, N. A. Makatsariya, G. Rizzo, G. C. Di Renzo, D. V. Blinov, L. L. Pankratyeva, V. I. Tsibizova | ||
| "... thrombosis by using low molecular weight heparins. ..." | ||
| Vol 16, No 2 (2022) | Masked polycythemia vera manifested by splanchnic venous thrombosis during pregnancy: a clinical case | Abstract similar documents |
| M. Yu. Nadinskaia, Kh. B. Kodzoeva, M. A. Sokolova, S. V. Apresyan, E. Yu. Kryzhanovskaya, A. A. Shchukina, E. A. Kitsenko | ||
| "... performed, as well as the appointment of low molecular weight heparin in the postoperative period ..." | ||
| Vol 9, No 2 (2015) | THROMBOTIC MICROANGIOPATHY IN THE PATHOGENESIS OF OBSTETRIC COMPLICATIONS | Abstract similar documents |
| S. V. Akinshina, V. O. Bitsadze, Z. K. Gadaeva, A. D. Makatsariya | ||
| "... ), hemolytic uremic syndrome (HUS), heparin-induced thrombocytopenia, HELLP-syndrome. Pregnancy presents one ..." | ||
| Vol 10, No 1 (2016) | HEART RHYTM DISORDERS AND THROMBOSIS. ANTICOAGULANT THERAPY OF CARDIAC ARRHYTHMIAS IN PREGNANCY | Abstract similar documents |
| A. D. Makatsariya, S. V. Akinshina, V. O. Bitsadze | ||
| "... anticoagulant therapy during all pregnancy. Acquired or genetic forms of thrombophilia also can increase ..." | ||
| 1 - 50 of 98 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
